Analysts have set 12-month price targets for CME Group, revealing an average target of $276.38, a high estimate of $305.00, ...

Additionally, Erste Group downgraded its rating on CME Group stock from Buy to Hold ... with significant trading volume achievements and varied analyst opinions on its financial prospects.

In terms of analyst opinions, Erste Group downgraded CME Group’s (NASDAQ:CME) stock rating from Buy to Hold, citing an expected slowdown in turnover and net profit growth. Conversely ...

analyst Benjamin Budish. Despite this, CME Group achieved record trading volumes in various products, driven by heightened market volatility. UBS maintained its Buy rating with a $305 target, ...

CME Group offers strong cash flow, market dominance, and a resilient business model. Click here to see why CME stock is a Buy ...

KBW analyst Kyle Voigt maintained a Hold rating on CME Group (CME – Research Report) today and set a price target of $273.00. The company’s shares closed yesterday at $282.31.

In a report released on June 6, Benjamin Budish from Barclays maintained a Buy rating on Marex Group plc (MRX – Research Report), with a price target of $52.00. The company’s ...

Following the initial dip, CME Group’s stock remained ... On Apr. 24, Morgan Stanley (MS) analyst Mike Cyprys reiterated an “Overweight” rating on CME and raised the price target from ...

CME Group has significantly outperformed ... On Apr. 24, Morgan Stanley (MS) analyst Mike Cyprys reiterated an “Overweight” rating on CME and raised the price target from $301 to $304.

Vanguard Real Estate Index Fund ETF Shares' high dividend appeal is outweighed by rising interest rates and liquidity risks.